Upcoming Catalysts On The Radar: ARQL & GBT


ASH abstracts coming 12/1. Looking forward to $ARQL update on reversible Btk inhib ARQ 531 for C481S mutants (Ibrutinib resistance) in B cell cancers and $GBT Hope Kids higher dose cohort for Voxelotor/sickle cell.

Click to see info on more upcoming small biopharma catalyst events.

#AmpFree

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon